VIZDATIO
Live / Allowed — Fifth extension granted (statement of use) (as of 21 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97689702
- Mark type
- Word mark
- Filed
- 23 Nov 2022
- Published for opposition
- 10 Oct 2023
- Attorney of record
- Nathan T. Harris
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals in the nature of eye drops for the treatment of dry eye disease and allergic conjunctivitis
Owner
- Aldeyra Therapeutics, Inc., Lexington, MA, US
- Aldeyra Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 22 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2026 — SOU EXTENSION 5 GRANTED
- 01 Jun 2026 — SOU EXTENSION 5 FILED
- 17 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Jan 2026 — ASSIGNED TO EXAMINER
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 4 GRANTED
- 29 Sept 2025 — SOU EXTENSION 4 FILED
- 29 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 3 GRANTED
- 06 May 2025 — SOU EXTENSION 3 FILED
- 06 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED